TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
HSDT

Helius Medical Technologies Inc Class A

Financial Services · Asset Management

2.90$ +1.4% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement HSDT
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– – – – 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
– – – – 12.3% 60.8% 113.6% 57.1% 58.8% 90.5% 111.9% 8.3%
– – – – 87.7% 39.2% -13.6% 42.9% 41.2% 9.5% -11.9% 91.7%
– – – – 2,079.3% 538.8% 693.2% 1,147.5% 541.6% 456.8% 703.7% 58.4%
– – – – 3,601.3% 1,104.3% 1,469.6% 2,332.6% 1,352.0% 1,491.6% 1,820.6% 384.4%
– – – – 5,668.2% 1,643.2% 2,115.9% 3,518.4% 2,012.7% 1,939.3% 2,661.7% 442.7%
– – – – -5,580.5% -1,604.0% -2,129.5% -3,475.5% -1,971.5% -1,929.8% -2,673.7% -351.0%
– – – – 407.5% 950.2% 38.7% 1.9% 106.0% 39.9% 3.3% 10.6%
– – – – -5,988.1% -653.8% -2,137.7% -3,473.6% -1,788.1% -1,374.2% -2,258.1% -679.6%
– – – – 828.2% -943.9% -29.2% -1.9% -192.4% -0.9% – –
– – – – -5,988.1% -653.8% -2,137.7% -3,473.6% -1,788.1% -1,374.2% -2,258.1% -679.6%
– – – – -5,975.7% -641.0% -2,064.8% -3,413.8% -1,842.9% -1,880.0% -2,654.4% -657.7%

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?